Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck.

Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck.

Item
http://www.wikidata.org/entity/Q34749411
The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future.Cancer therapy and cardiovascular risk: focus on bevacizumab.Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinomaCCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximabPhase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma.Immunohistochemical biomarkers and volumetric parameters for predicting radiotherapy-based outcomes in patients with p16-negative pharyngeal cancerCD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches.Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer.Realizing the Potential of Vascular Targeted Therapy: The Rationale for Combining Vascular Disrupting Agents and Anti-Angiogenic Agents to Treat Cancer.RGD-K5 PET/CT in patients with advanced head and neck cancer treated with concurrent chemoradiotherapy: Results from a pilot study.The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules.α-Tocopheryl Succinate-Based Polymeric Nanoparticles for the Treatment of Head and Neck Squamous Cell Carcinoma
P2860

Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck.

Item
http://www.wikidata.org/entity/Q34749411
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Phase II study of bevacizumab ...... arcinoma of the head and neck.
@ast
Phase II study of bevacizumab ...... arcinoma of the head and neck.
@en
Phase II study of bevacizumab ...... arcinoma of the head and neck.
@nl
type
label
Phase II study of bevacizumab ...... arcinoma of the head and neck.
@ast
Phase II study of bevacizumab ...... arcinoma of the head and neck.
@en
Phase II study of bevacizumab ...... arcinoma of the head and neck.
@nl
prefLabel
Phase II study of bevacizumab ...... arcinoma of the head and neck.
@ast
Phase II study of bevacizumab ...... arcinoma of the head and neck.
@en
Phase II study of bevacizumab ...... arcinoma of the head and neck.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Phase II study of bevacizumab ...... arcinoma of the head and neck.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932